ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Insights, Forecast to 2030
Published Date: July 2024
|
Report Code: QYRE-Auto-5U12923
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Research Report 2023
BUY CHAPTERS

Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Insights, Forecast to 2030

Code: QYRE-Auto-5U12923
Report
July 2024
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Dako (Agilent Technologies)
Merck
BD
Abbott
Genesys Biolabs (20/20GeneSystems)
Affymetrix Inc
Agendia
ALMAC
Arrayit
Biocartic
BG Medicine
KEGG EXPRESSION Database
Thermo Fisher
BGI

Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size

The global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market is projected to grow from US$ 22500 million in 2024 to US$ 29810 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period.

Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market

Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market

A biomarker is, according to the US National Institutes of Health, “a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention.”
Biomarkers make take the form of cellular characteristics, metabolites (e.g. sugars, lipids and hormones), molecular variations, or physical features (e.g., clinical symptoms) and are assessed accordingly, via measurement, annotation, documents, and images.
Increasingly, the discovery of novel biomarkers is closely associated with the advances in molecular biology techniques that can be accessed through analysis of DNA, RNA or proteins.
We can discriminate four main types of molecular biomarkers:
• Genomic biomarkers: Based on the analysis of DNA (deoxyribonucleic acid) profiles, especially the analysis of SNPs (single nucleotide polymorphisms), i.e. identification of punctual variations in genomic DNA.
• Transcriptomic biomarkers: Base on the analysis of RNA expression profiles.
• Proteomic biomarkers: Base on the analysis of the protein profiles.
• Metabolomic biomarkers: Base on the analysis of metabolites (metabolites are the intermediates and products of metabolism).
Commercializing biomarkers is the path that a biomarker could be used in therapeutic or diagnostic. In this report mainly covers consumables, services, software of this market.
Market Analysis and Insights: Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market
The major players in global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market include Roche, Dako (Agilent Technologies), Affymetrix, etc. The top 3 players occupy about 10% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Consumables is the main type, with a share about 60%. The main applications include Oncology, Cardiology, Neurology, etc.
Report Covers:
This report presents an overview of global market for Commercializing Biomarkers in Therapeutic and Diagnostic Applications market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Commercializing Biomarkers in Therapeutic and Diagnostic Applications, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Commercializing Biomarkers in Therapeutic and Diagnostic Applications, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Commercializing Biomarkers in Therapeutic and Diagnostic Applications revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Commercializing Biomarkers in Therapeutic and Diagnostic Applications revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Report

Report Metric Details
Report Name Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market
Accounted market size in 2024 US$ 22500 million
Forecasted market size in 2030 US$ 29810 million
CAGR 4.8
Base Year 2024
Forecasted years 2024 - 2030
Segment by Type
  • Consumables
  • Services
  • Software
Segment by Application
  • Oncology
  • Cardiology
  • Neurology
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Dako (Agilent Technologies), Merck, BD, Abbott, Genesys Biolabs (20/20GeneSystems), Affymetrix, Agendia, ALMAC, Arrayit, Biocartic, BG Medicine, KEGG EXPRESSION Database, Thermo Fisher, BGI
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Commercializing Biomarkers in Therapeutic and Diagnostic Applications in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Commercializing Biomarkers in Therapeutic and Diagnostic Applications revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market growing?

Ans: The Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market witnessing a CAGR of 4.8 during the forecast period 2024-2030.

What is the Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market size in 2030?

Ans: The Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market size in 2030 will be US$ 29810 million.

What is the market share of major companies in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market?

Ans: The top 3 players occupy about 10% shares of the global market.

What is the Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market share by type?

Ans: Consumables is the main type, with a share about 60%.

Who are the main players in the Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market report?

Ans: The main players in the Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market are Roche, Dako (Agilent Technologies), Merck, BD, Abbott, Genesys Biolabs (20/20GeneSystems), Affymetrix, Agendia, ALMAC, Arrayit, Biocartic, BG Medicine, KEGG EXPRESSION Database, Thermo Fisher, BGI

What are the Application segmentation covered in the Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market report?

Ans: The Applications covered in the Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market report are Oncology, Cardiology, Neurology, Other

What are the Type segmentation covered in the Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market report?

Ans: The Types covered in the Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market report are Consumables, Services, Software

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Consumables
1.2.3 Services
1.2.4 Software
1.3 Market by Application
1.3.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Perspective (2019-2030)
2.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Growth Trends by Region
2.2.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Historic Market Size by Region (2019-2024)
2.2.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecasted Market Size by Region (2025-2030)
2.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Dynamics
2.3.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Industry Trends
2.3.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Drivers
2.3.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Challenges
2.3.4 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Players
3.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Players (2019-2024)
3.1.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Players (2019-2024)
3.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Commercializing Biomarkers in Therapeutic and Diagnostic Applications, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Concentration Ratio
3.4.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue in 2023
3.5 Global Key Players of Commercializing Biomarkers in Therapeutic and Diagnostic Applications Head office and Area Served
3.6 Global Key Players of Commercializing Biomarkers in Therapeutic and Diagnostic Applications, Product and Application
3.7 Global Key Players of Commercializing Biomarkers in Therapeutic and Diagnostic Applications, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Breakdown Data by Type
4.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Historic Market Size by Type (2019-2024)
4.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecasted Market Size by Type (2025-2030)
5 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Breakdown Data by Application
5.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Historic Market Size by Application (2019-2024)
5.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (2019-2030)
6.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type
6.2.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2019-2024)
6.2.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2025-2030)
6.2.3 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type (2019-2030)
6.3 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application
6.3.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2019-2024)
6.3.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2025-2030)
6.3.3 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Application (2019-2030)
6.4 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country
6.4.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2019-2024)
6.4.3 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (2019-2030)
7.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type
7.2.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2019-2024)
7.2.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2025-2030)
7.2.3 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type (2019-2030)
7.3 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application
7.3.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2019-2024)
7.3.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2025-2030)
7.3.3 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Application (2019-2030)
7.4 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country
7.4.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2019-2024)
7.4.3 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (2019-2030)
8.2 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type
8.2.1 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2019-2024)
8.2.2 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2025-2030)
8.2.3 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type (2019-2030)
8.3 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application
8.3.1 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2019-2024)
8.3.2 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2025-2030)
8.3.3 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (2019-2030)
9.2 Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type
9.2.1 Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2019-2024)
9.2.2 Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2025-2030)
9.2.3 Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type (2019-2030)
9.3 Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application
9.3.1 Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2019-2024)
9.3.2 Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2025-2030)
9.3.3 Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Application (2019-2030)
9.4 Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Region
9.4.1 Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Region (2019-2024)
9.4.3 Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type
10.2.1 Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application
10.3.1 Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country
10.4.1 Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
11.1.4 Roche Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
11.1.5 Roche Recent Developments
11.2 Dako (Agilent Technologies)
11.2.1 Dako (Agilent Technologies) Company Details
11.2.2 Dako (Agilent Technologies) Business Overview
11.2.3 Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
11.2.4 Dako (Agilent Technologies) Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
11.2.5 Dako (Agilent Technologies) Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
11.3.4 Merck Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
11.3.5 Merck Recent Developments
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
11.4.4 BD Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
11.4.5 BD Recent Developments
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
11.5.4 Abbott Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
11.5.5 Abbott Recent Developments
11.6 Genesys Biolabs (20/20GeneSystems)
11.6.1 Genesys Biolabs (20/20GeneSystems) Company Details
11.6.2 Genesys Biolabs (20/20GeneSystems) Business Overview
11.6.3 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
11.6.4 Genesys Biolabs (20/20GeneSystems) Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
11.6.5 Genesys Biolabs (20/20GeneSystems) Recent Developments
11.7 Affymetrix
11.7.1 Affymetrix Company Details
11.7.2 Affymetrix Business Overview
11.7.3 Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
11.7.4 Affymetrix Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
11.7.5 Affymetrix Recent Developments
11.8 Agendia
11.8.1 Agendia Company Details
11.8.2 Agendia Business Overview
11.8.3 Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
11.8.4 Agendia Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
11.8.5 Agendia Recent Developments
11.9 ALMAC
11.9.1 ALMAC Company Details
11.9.2 ALMAC Business Overview
11.9.3 ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
11.9.4 ALMAC Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
11.9.5 ALMAC Recent Developments
11.10 Arrayit
11.10.1 Arrayit Company Details
11.10.2 Arrayit Business Overview
11.10.3 Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
11.10.4 Arrayit Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
11.10.5 Arrayit Recent Developments
11.11 Biocartic
11.11.1 Biocartic Company Details
11.11.2 Biocartic Business Overview
11.11.3 Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
11.11.4 Biocartic Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
11.11.5 Biocartic Recent Developments
11.12 BG Medicine
11.12.1 BG Medicine Company Details
11.12.2 BG Medicine Business Overview
11.12.3 BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
11.12.4 BG Medicine Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
11.12.5 BG Medicine Recent Developments
11.13 KEGG EXPRESSION Database
11.13.1 KEGG EXPRESSION Database Company Details
11.13.2 KEGG EXPRESSION Database Business Overview
11.13.3 KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
11.13.4 KEGG EXPRESSION Database Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
11.13.5 KEGG EXPRESSION Database Recent Developments
11.14 Thermo Fisher
11.14.1 Thermo Fisher Company Details
11.14.2 Thermo Fisher Business Overview
11.14.3 Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
11.14.4 Thermo Fisher Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
11.14.5 Thermo Fisher Recent Developments
11.15 BGI
11.15.1 BGI Company Details
11.15.2 BGI Business Overview
11.15.3 BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
11.15.4 BGI Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
11.15.5 BGI Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Roche
Dako (Agilent Technologies)
Merck
BD
Abbott
Genesys Biolabs (20/20GeneSystems)
Affymetrix Inc
Agendia
ALMAC
Arrayit
Biocartic
BG Medicine
KEGG EXPRESSION Database
Thermo Fisher
BGI
List of Tables
    Table 1. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Consumables
    Table 3. Key Players of Services
    Table 4. Key Players of Software
    Table 5. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Region (2019-2024)
    Table 9. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Region (2025-2030)
    Table 11. Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Trends
    Table 12. Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Drivers
    Table 13. Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Challenges
    Table 14. Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Restraints
    Table 15. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Players (2019-2024)
    Table 17. Global Top Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications as of 2023)
    Table 18. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Commercializing Biomarkers in Therapeutic and Diagnostic Applications, Headquarters and Area Served
    Table 21. Global Key Players of Commercializing Biomarkers in Therapeutic and Diagnostic Applications, Product and Application
    Table 22. Global Key Players of Commercializing Biomarkers in Therapeutic and Diagnostic Applications, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Type (2019-2024)
    Table 26. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Type (2025-2030)
    Table 28. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Application (2019-2024)
    Table 30. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Application (2025-2030)
    Table 32. North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Roche Company Details
    Table 65. Roche Business Overview
    Table 66. Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
    Table 67. Roche Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024) & (US$ Million)
    Table 68. Roche Recent Developments
    Table 69. Dako (Agilent Technologies) Company Details
    Table 70. Dako (Agilent Technologies) Business Overview
    Table 71. Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
    Table 72. Dako (Agilent Technologies) Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024) & (US$ Million)
    Table 73. Dako (Agilent Technologies) Recent Developments
    Table 74. Merck Company Details
    Table 75. Merck Business Overview
    Table 76. Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
    Table 77. Merck Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024) & (US$ Million)
    Table 78. Merck Recent Developments
    Table 79. BD Company Details
    Table 80. BD Business Overview
    Table 81. BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
    Table 82. BD Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024) & (US$ Million)
    Table 83. BD Recent Developments
    Table 84. Abbott Company Details
    Table 85. Abbott Business Overview
    Table 86. Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
    Table 87. Abbott Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024) & (US$ Million)
    Table 88. Abbott Recent Developments
    Table 89. Genesys Biolabs (20/20GeneSystems) Company Details
    Table 90. Genesys Biolabs (20/20GeneSystems) Business Overview
    Table 91. Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
    Table 92. Genesys Biolabs (20/20GeneSystems) Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024) & (US$ Million)
    Table 93. Genesys Biolabs (20/20GeneSystems) Recent Developments
    Table 94. Affymetrix Company Details
    Table 95. Affymetrix Business Overview
    Table 96. Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
    Table 97. Affymetrix Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024) & (US$ Million)
    Table 98. Affymetrix Recent Developments
    Table 99. Agendia Company Details
    Table 100. Agendia Business Overview
    Table 101. Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
    Table 102. Agendia Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024) & (US$ Million)
    Table 103. Agendia Recent Developments
    Table 104. ALMAC Company Details
    Table 105. ALMAC Business Overview
    Table 106. ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
    Table 107. ALMAC Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024) & (US$ Million)
    Table 108. ALMAC Recent Developments
    Table 109. Arrayit Company Details
    Table 110. Arrayit Business Overview
    Table 111. Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
    Table 112. Arrayit Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024) & (US$ Million)
    Table 113. Arrayit Recent Developments
    Table 114. Biocartic Company Details
    Table 115. Biocartic Business Overview
    Table 116. Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
    Table 117. Biocartic Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024) & (US$ Million)
    Table 118. Biocartic Recent Developments
    Table 119. BG Medicine Company Details
    Table 120. BG Medicine Business Overview
    Table 121. BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
    Table 122. BG Medicine Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024) & (US$ Million)
    Table 123. BG Medicine Recent Developments
    Table 124. KEGG EXPRESSION Database Company Details
    Table 125. KEGG EXPRESSION Database Business Overview
    Table 126. KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
    Table 127. KEGG EXPRESSION Database Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024) & (US$ Million)
    Table 128. KEGG EXPRESSION Database Recent Developments
    Table 129. Thermo Fisher Company Details
    Table 130. Thermo Fisher Business Overview
    Table 131. Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
    Table 132. Thermo Fisher Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024) & (US$ Million)
    Table 133. Thermo Fisher Recent Developments
    Table 134. BGI Company Details
    Table 135. BGI Business Overview
    Table 136. BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
    Table 137. BGI Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024) & (US$ Million)
    Table 138. BGI Recent Developments
    Table 139. Research Programs/Design for This Report
    Table 140. Key Data Information from Secondary Sources
    Table 141. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type: 2023 VS 2030
    Figure 3. Consumables Features
    Figure 4. Services Features
    Figure 5. Software Features
    Figure 6. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Application: 2023 VS 2030
    Figure 8. Oncology Case Studies
    Figure 9. Cardiology Case Studies
    Figure 10. Neurology Case Studies
    Figure 11. Other Case Studies
    Figure 12. Commercializing Biomarkers in Therapeutic and Diagnostic Applications Report Years Considered
    Figure 13. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Region: 2023 VS 2030
    Figure 16. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Players in 2023
    Figure 17. Global Top Commercializing Biomarkers in Therapeutic and Diagnostic Applications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue in 2023
    Figure 19. North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type (2019-2030)
    Figure 21. North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Application (2019-2030)
    Figure 22. North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Country (2019-2030)
    Figure 23. United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type (2019-2030)
    Figure 27. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Application (2019-2030)
    Figure 28. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Country (2019-2030)
    Figure 29. Germany Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type (2019-2030)
    Figure 37. China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Application (2019-2030)
    Figure 38. Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type (2019-2030)
    Figure 40. Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Application (2019-2030)
    Figure 41. Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Region (2019-2030)
    Figure 42. Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Country (2019-2030)
    Figure 52. Brazil Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Roche Revenue Growth Rate in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
    Figure 59. Dako (Agilent Technologies) Revenue Growth Rate in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
    Figure 60. Merck Revenue Growth Rate in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
    Figure 61. BD Revenue Growth Rate in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
    Figure 62. Abbott Revenue Growth Rate in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
    Figure 63. Genesys Biolabs (20/20GeneSystems) Revenue Growth Rate in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
    Figure 64. Affymetrix Revenue Growth Rate in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
    Figure 65. Agendia Revenue Growth Rate in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
    Figure 66. ALMAC Revenue Growth Rate in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
    Figure 67. Arrayit Revenue Growth Rate in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
    Figure 68. Biocartic Revenue Growth Rate in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
    Figure 69. BG Medicine Revenue Growth Rate in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
    Figure 70. KEGG EXPRESSION Database Revenue Growth Rate in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
    Figure 71. Thermo Fisher Revenue Growth Rate in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
    Figure 72. BGI Revenue Growth Rate in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2019-2024)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Plant-based Soft Capsule - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-26V13549
Mon Nov 11 00:00:00 UTC 2024

Add to Cart

Pharmaceutical Grade Sodium Hyaluronate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-17N14065
Mon Nov 11 00:00:00 UTC 2024

Add to Cart

Pharmaceutical Fluid Bed System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-6Q14792
Fri Nov 08 00:00:00 UTC 2024

Add to Cart

Medical Microbial Incubators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-30W13258
Thu Nov 07 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions